...
首页> 外文期刊>The journal of clinical investigation >The telomerase inhibitor PinX1 is a major haploinsufficient tumor suppressor essential for chromosome stability in mice
【24h】

The telomerase inhibitor PinX1 is a major haploinsufficient tumor suppressor essential for chromosome stability in mice

机译:端粒酶抑制剂PinX1是主要的单倍体肿瘤抑制因子,对小鼠的染色体稳定性至关重要

获取原文

摘要

Telomerase is activated in most human cancers and is critical for cancer cell growth. However, little is known about the significance of telomerase activation in chromosome instability and cancer initiation. The gene encoding the potent endogenous telomerase inhibitor PinX1 (PIN2/TRF1-interacting, telomerase inhibitor 1) is located at human chromosome 8p23, a region frequently exhibiting heterozygosity in many common human cancers, but the function or functions of PinX1 in development and tumorigenesis are unknown. Here we have shown that PinX1 is a haploinsufficient tumor suppressor essential for chromosome stability in mice. We found that PinX1 expression was reduced in most human breast cancer tissues and cell lines. Furthermore, PinX1 heterozygosity and PinX1 knockdown in mouse embryonic fibroblasts activated telomerase and led to concomitant telomerase-dependent chromosomal instability. Moreover, while PinX1-null mice were embryonic lethal, most PinX1~(+/–) mice spontaneously developed malignant tumors with evidence of chromosome instability. Notably, most PinX1 mutant tumors were carcinomas and shared tissues of origin with human cancer types linked to 8p23. PinX1 knockout also shifted the tumor spectrum of p53 mutant mice from lymphoma toward epithelial carcinomas. Thus, PinX1 is a major haploinsufficient tumor suppressor essential for maintaining telomerase activity and chromosome stability. These findings uncover what we believe to be a novel role for PinX1 and telomerase in chromosome instability and cancer initiation and suggest that telomerase inhibition may be potentially used to treat cancers that overexpress telomerase.
机译:端粒酶在大多数人类癌症中均被激活,并且对于癌细胞的生长至关重要。但是,关于端粒酶激活在染色体不稳定和癌症发生中的重要性了解甚少。编码有效内源性端粒酶抑制剂PinX1(与PIN2 / TRF1相互作用,端粒酶抑制剂1)的基因位于人类染色体8p23,该区域在许多常见的人类癌症中经常表现出杂合性,但是PinX1在发育和肿瘤发生中的功能是未知。在这里,我们显示了PinX1是单倍型不足的肿瘤抑制因子,对小鼠的染色体稳定性至关重要。我们发现PinX1表达在大多数人类乳腺癌组织和细胞系中降低。此外,在小鼠胚胎成纤维细胞中,PinX1杂合性和PinX1敲低激活了端粒酶,并导致了端粒酶依赖性染色体不稳定性。而且,虽然PinX1无效的小鼠具有胚胎致死性,但大多数PinX1〜(+/–)小鼠自发发展为具有染色体不稳定迹象的恶性肿瘤。值得注意的是,大多数PinX1突变型肿瘤都是癌,并且是与8p23相关的人类癌症类型的共同起源组织。 PinX1基因敲除也将p53突变小鼠的肿瘤谱从淋巴瘤转移到上皮癌。因此,PinX1是主要的单倍型肿瘤抑制因子,对于维持端粒酶活性和染色体稳定性至关重要。这些发现揭示了我们认为PinX1和端粒酶在染色体不稳定性和癌症发生中的新作用,并表明端粒酶抑制作用可能被用于治疗过度表达端粒酶的癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号